NIH awards DoseOptics an additional $2 Million to improve radiation therapy safety
September 20, 2016 | DoseOptics
DoseOptics, founded by professors Brian Pogue and Scott Davis Th’08, has been awarded an NIH Phase II Small Business Innovation Research (SBIR) grant totaling $2 million over 2 years.
Avedro’s non-surgical procedure is a promising new treatment for vision improvement for low myopia, according to the results of two studies announced today.
NEPDC and TREAT Award $150K to Medical Device Innovators
September 8, 2016 | NEPDC
Four winners announced in 2016 Target Challenge grant competition held by New England Pediatric Device Consortium (NEPDC), Center for Translation of Rehabilitation Engineering Advances and Technology (TREAT), Pediatric Orthopaedic Society of North America (POSNA), and the Foundation for Physical Therapy.
Blame airlines, not weather, for most U.S. flight delays
August 23, 2016 | Chicago Tribune
Professor Vikrant Vaze's research supports the findings that airline miscues are now the biggest cause of flight delays in the U.S.
NIH Funds Dartmouth Study of Cellular Disease Processes
August 8, 2016 | Dartmouth Now
The five-year, $12.45 million grant supports an interdisciplinary project for junior faculty including engineering professor Karl Griswold who will co-direct the "molecular tools core."
Can Virtual Reality Help Astronauts Keep Their Cool?
August 4, 2016 | Discover Magazine
Professor Jay Buckey and his colleagues are using calming imagery to see if virtual scenes reduce stress levels.
One proposal was from Dartmouth engineering professor Ulrike Wegst for "Structure-Property-Processing Correlations in Freeze-Cast Biomimetic Materials."
Dartmouth Hosts Fellowships for Young African Leaders
August 2, 2016 | Dartmouth Now
The business and entrepreneurship institute is part of an Obama administration initiative.
2016’s Most & Least Energy-Expensive States
July 19, 2016 | WalletHub
For insight into the various ways Americans can reduce their dependence on traditional energy sources, we asked a panel of energy and policy experts to weigh in.
Avedro Inc., an ophthalmic pharmaceutical and medical device company founded by Dartmouth engineering professor Stuart Trembly, received approval from FDA for Photrexa Viscous, Photrexa and the KXL System used for the treatment of corneal ectasia.